John Jameson

John Jameson is an accomplished professional in regulatory affairs, currently serving on the Regulatory Affairs Committee of the American Society of Gene & Cell Therapy and as Senior Director of Regulatory Affairs at Asklepios BioPharmaceutical, Inc. With extensive experience in the gene therapy sector, John's leadership spans the preparation of regulatory submissions, successful interactions with health authorities, and strategic oversight of multiple gene therapy programs. Previous roles include Senior Director at Sio Gene Therapies, where John played a pivotal role in the first FDA-cleared gene therapy for a rare lysosomal storage disease, and Senior Scientist at Cardinal Health, providing innovative regulatory leadership for advanced therapy product development. John’s earlier career includes significant roles at the FDA, Mayo Clinic, and Lawrence Berkeley National Laboratory, alongside a strong educational foundation with a PhD and BS in Biomedical Engineering from Marquette University and the University of Virginia, respectively.